Barclays PLC Kala Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.3 - $1.31 $6,671 - $29,133
-22,239 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.61 - $1.84 $30,947 - $93,348
-50,733 Reduced 69.52%
22,239 $31,000
Q4 2021

Feb 14, 2022
BUY
$1.16 - $2.74 $45,146 - $106,638
38,919 Added 114.29%
72,972 $88,000
Q3 2021

Nov 09, 2021
BUY
$2.62 - $5.43 $26,951 - $55,858
10,287 Added 43.28%
34,053 $88,000
Q2 2021

Aug 13, 2021
SELL
$5.06 - $8.15 $182,509 - $293,962
-36,069 Reduced 60.28%
23,766 $125,000
Q1 2021

May 13, 2021
BUY
$6.24 - $9.58 $292,393 - $448,899
46,858 Added 361.08%
59,835 $403,000
Q4 2020

Feb 11, 2021
SELL
$6.28 - $8.79 $98,972 - $138,530
-15,760 Reduced 54.84%
12,977 $88,000
Q3 2020

Nov 12, 2020
SELL
$7.5 - $11.11 $981,420 - $1.45 Million
-130,856 Reduced 81.99%
28,737 $218,000
Q2 2020

Aug 12, 2020
BUY
$8.33 - $13.79 $1.21 Million - $2 Million
144,733 Added 973.98%
159,593 $1.68 Million
Q1 2020

May 13, 2020
SELL
$3.83 - $8.79 $29,016 - $66,593
-7,576 Reduced 33.77%
14,860 $131,000
Q4 2019

Feb 10, 2020
BUY
$3.36 - $4.81 $30,619 - $43,833
9,113 Added 68.4%
22,436 $83,000
Q3 2019

Nov 14, 2019
SELL
$3.57 - $6.58 $9,464 - $17,443
-2,651 Reduced 16.6%
13,323 $50,000
Q2 2019

Aug 14, 2019
BUY
$4.93 - $8.8 $41,850 - $74,703
8,489 Added 113.41%
15,974 $102,000
Q1 2019

May 15, 2019
BUY
$5.19 - $8.97 $28,192 - $48,725
5,432 Added 264.59%
7,485 $61,000
Q4 2018

Feb 14, 2019
SELL
$4.29 - $9.94 $18,399 - $42,632
-4,289 Reduced 67.63%
2,053 $10,000
Q3 2018

Nov 14, 2018
SELL
$9.54 - $13.87 $28,801 - $41,873
-3,019 Reduced 32.25%
6,342 $62,000
Q2 2018

Aug 14, 2018
BUY
$13.3 - $17.49 $49,409 - $64,975
3,715 Added 65.8%
9,361 $129,000
Q1 2018

May 15, 2018
BUY
$12.26 - $18.98 $25,684 - $39,763
2,095 Added 59.0%
5,646 $89,000
Q4 2017

Feb 14, 2018
SELL
$13.68 - $23.17 $114,884 - $194,581
-8,398 Reduced 70.28%
3,551 $65,000
Q3 2017

Nov 14, 2017
BUY
$19.86 - $26.53 $237,307 - $317,006
11,949
11,949 $273,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.74M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email